Parkinson's disease is associated with oxidative stress: Comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients

Journal of Neural Transmission

Volumn 108, Issue 10, 2001, Pages 1135-1148

  Serra, J A ^a   Dominguez R O ^b   De Lustig, E S ^c   Guareschi, E M ^d   Famulari, A L ^b   Bartolome E L ^b   Marschoff, E R ^e  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b Asociacion de Beneficencia Hospital Sirio Libanes Buenos Aires   (Argentina)

^c Instituto de Oncologia Angel H Roffo   (Argentina)

^d Laboratorio Especializado para Las Investigaciones   (Argentina)

^e UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antioxidant system; Cu Zn superoxide dismutase; Dementia of the Alzheimer's type; Oxygen free radicals; Parkinson's disease; Peripheral markers; Vascular dementia

Indexed keywords

ANTIOXIDANT; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; ENZYME ASSAY; ERYTHROCYTE LEVEL; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANTIOXIDANTS; DEMENTIA, VASCULAR; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PARKINSON DISEASE; STATISTICS, NONPARAMETRIC;

EID: 0034750776     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020170003     Document Type: Article

References (51)

1. Assay of glutathione, glutathione disulfides and glutathione mixed disulfides in biological samples
2. Oxidative markers of injury in MPP+ and malonate-treated rat mesencephalic cultures
3. Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging
4. Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: A possible new subtype of familial ALS
5. Iron-melanin interaction and lipid peroxidation: Implications for Parkinson's disease
6. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects
7. Hydroperoxide metabolism in mammalian organs
8. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's Disease Diagnostic and Treatment Centers
9. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenyl-pyridinium: Evidence for free radical involvement
10. Normative data and screening power of a shortened version of the Token Test
11. Increased nigral iron content and alterations in other metals ions occurring in brain in Parkinson's disease
12. The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls
13. Protein involved in the regulation of intracellular iron (H and L-ferritin, iron regulatory protein) in the mesencephalon of patients with Parkinson's disease
14. Mini mental state: A practical method for grading the cognitive state of patient for the clinician
15. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: Characterization and comparison with homogenates and microsomes
16. Hydroperoxide initiated chemiluminescence: An assay of oxidative in biopsies of heart and liver
17. Neuromelanin-acontaining neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: A LAMMA study
18. Rating scale for depression
19. Immunohisto-chemical studies on complexes I, II, III and IV of mitochondria in Parkinson's disease
20. Parkinsonism: Onset, progression and mortality
21. What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathological study
22. A new clinical scale for the staging of dementia (CDR)
23. Cell death mechanisms in Parkinson's disease
24. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease
25. Developmental aspects of experimental pulmonary oxygen toxicity
26. Luminol luminescence induced by 2-2′azo-bis (2 amidinopropane) thermolysis
27. Protein measurement with the Folin phenol reagent
28. Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging
29. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
30. Neurological deterioration, heterogeneity of Alzheimer disease and antioxidant profiles: A four trials meta-analysis
31. Oxygen toxicity protecting enzymes in the Parkinson's disease: Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus
32. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force of Alzheimer's disease
33. Importance of Se-glutathione peroxidase, catalase and Cu/Zn-SOD for cell survival against oxidative stress
34. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase
35. Dopaminergic neurotoxins. MPTP and MPP+, inhibit mitochondrial NADH-ubiquinone oxido-reductase activity
36. Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts
37. Protective effect of nitric oxide against iron-induced neuronal damage
38. Motor-neuron astrocyte interactions and levels of Cu, Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis
39. Glutathione S-transferase polymorphism in Parkinson's disease
40. The global deterioration scale for assessment of primary degenerative dementia
41. A new rating scale for Alzheimer's disease
42. Neuronal death caused by apoptosis in Parkinson disease
43. Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first-degree relatives
44. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
45. Metabolism of oxygen derivatives in Down's syndrome
46. Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains
47. Superoxide dismutase, aging, and degenerative disease